
|Articles|April 8, 2020
PRISYM ID Offers PRISYM 360 Platform for COVID-19 Trials
Advertisement
PRISYM ID has announced its PRISYM 360 SaaS clinical trials labeling solution is live with customers and available to those pharmaceutical and trials organizations who need entry to clinical label printing. PRISYM 360 is a cloud-based, ready to use version of its clinical trials SaaS labeling platform including a pre-validated pack with industry standard print processes.
	For more information, click 
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
MATTERHORN Trial Findings Signal Paradigm Shift in Early Gastric Cancer Care
2
Reducing Site Burden Through Better Technology Integration in Clinical Trials
3
ACT Brief: AstraZeneca Expands Immunotherapy Reach as Thermo Fisher’s $8.8B Deal Signals New Phase for Digital Trials
4
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
5






.png)



.png)



.png)
.png)
